In this paper, based on the target of GLP-1, the mechanism of action of GLP-1 in obesity treatment was deeply studied, and the drugs approved and designed for obesity treatment based on GLP-1 target were elaborated in detail. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.